An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment

An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment

Recently, metastatic renal cell carcinoma (mRCC) treatment has changed dramatically with the onset of new therapies against molecular targets replacing immunotherapy as standard treatment. We report the case of a 49-year-old patient with a moderately differentiated renal clear cell carcinoma without...

Full description

Bibliographic Details
Main Authors: Luis Chara, Beatriz Rodríguez, Esther Holgado, Natalia Ramírez, Isabel Fernández-Rañada, Nicolás Mohedano, Alberto Arcediano, Inés García, Javier Cassinello
Format: Article
Language:English
Published: Karger Publishers 2011-12-01
Series:Case Reports in Oncology
Subjects:
Complete response
Renal cell carcinoma
Thyroid metastases
Duodenal metastases
Duodenopancreatectomy
Sunitinib
Long-term survivorship
Online Access:http://www.karger.com/Article/FullText/335016

Internet

http://www.karger.com/Article/FullText/335016

Similar Items